Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Everolimus & pancreatic neuroendocrine tumors, Everolimus is FDA‑approved for adult patients with progressive Pancreatic neuroendocrine tumors (PanNETs / PETs / PNETs) that are unresectable, locally advanced, or metastatic and have disease progression (1, 2, 3).
The European Medicines Agency (EMA) also authorizes everolimus for unresectable or metastatic, well‑ or moderately differentiated neuroendocrine tumors of pancreatic origin in adults with progressive disease (4).
In a randomize…